Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A
Published October 5, 2022 · Recall initiated: September 21, 2022
Summary
FDA records drug Class II recall D-1542-2022, published October 5, 2022 and initiated September 21, 2022. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 3,931 cartons; Lot: Lot 7105130, exp 9/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Viatris Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot 7105130, exp 9/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDALevothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b)December 18, 2024
- FDALevothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-countDecember 18, 2024
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by:October 5, 2022
- FDANeoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin CapsulesOctober 5, 2022
Questions about this recall
Was Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A recalled?
Yes. FDA published recall D-1542-2022 on October 5, 2022. Reported hazard: Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter